Intraarterial administration of abciximab for thromboembolic events occurring during aneurysm coil placement
C Mounayer, M Piotin, S Baldi… - American Journal of …, 2003 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Platelet-derived thrombi may occur during intracranial
aneurysm coiling. We report a series of 13 patients treated with intraarterial Abciximab for …
aneurysm coiling. We report a series of 13 patients treated with intraarterial Abciximab for …
Abciximab treatment modalities for thromboembolic events related to aneurysm coiling
M Aggour, L Pierot, K Kadziolka, P Gomis… - Operative …, 2010 - journals.lww.com
BACKGROUND: Thromboembolic complications are the most common cause of
periprocedural morbidity associated with the endovascular treatment of intracranial …
periprocedural morbidity associated with the endovascular treatment of intracranial …
Abciximab is a safe rescue therapy in thromboembolic events complicating cerebral aneurysm coil embolization: single center experience in 42 cases and review of …
T Ries, S Siemonsen, U Grzyska, H Zeumer, J Fiehler - Stroke, 2009 - Am Heart Assoc
Background and Purpose—The purpose of this study was to estimate the safety and efficacy
of abciximab treatment in combination with prophylactic heparin, acetylsalicylic acid (ASA) …
of abciximab treatment in combination with prophylactic heparin, acetylsalicylic acid (ASA) …
Abciximab for treatment of thromboembolic complications during endovascular coiling of intracranial aneurysms
RG Jones, I Davagnanam, S Colley… - American journal …, 2008 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Thromboembolism is a recognized complication occurring
during endovascular coil embolization of intracranial aneurysms. Recently, there has been …
during endovascular coil embolization of intracranial aneurysms. Recently, there has been …
Abciximab in patients with ruptured intracranial aneurysms
RI Aviv, R O'Neill, MC Patel… - American journal of …, 2005 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Experience with intravenous abciximab to manage
thromboembolism during treatment of ruptured intracranial aneurysms is limited. We present …
thromboembolism during treatment of ruptured intracranial aneurysms is limited. We present …
Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab
JK Song, Y Niimi, PM Fernandez… - American Journal …, 2004 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The management of thrombus formation during coil
placement in an intracranial aneurysm is important in minimizing periprocedural morbidity …
placement in an intracranial aneurysm is important in minimizing periprocedural morbidity …
Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications
JH Park, JE Kim, SH Sheen, CK Jung, BJ Kwon… - Journal of …, 2008 - thejns.org
Object Experience with intraarterial abciximab for the treatment of thromboembolism during
endovascular coil embolization is limited. The authors report the outcome of intraarterial …
endovascular coil embolization is limited. The authors report the outcome of intraarterial …
Abciximab for thrombolysis during intracranial aneurysm coiling
J Gralla, ATM Rennie, RA Corkill, ST Lalloo… - Neuroradiology, 2008 - Springer
Introduction Thrombotic events are a common and severe complication of endovascular
aneurysm treatment with significant impact on patients' outcome. This study evaluates risk …
aneurysm treatment with significant impact on patients' outcome. This study evaluates risk …
Management of intraprocedural arterial thrombus in cerebral aneurysm embolization with abciximab: technical case report
MJ Alexander, GR Duckwiler, YP Gobin, F Viñuela - Neurosurgery, 2002 - journals.lww.com
OBJECTIVE AND IMPORTANCE: Thromboembolic complications after cerebral aneurysm
treatment with Guglielmi detachable coils (Boston Scientific/Target, Fremont, CA) are not …
treatment with Guglielmi detachable coils (Boston Scientific/Target, Fremont, CA) are not …
Intra-arterial abciximab for the treatment of thrombus formation during coil embolization of intracranial aneurysms
I Linfante, V Etezadi, V Andreone, M DeLeo… - Journal of …, 2010 - jnis.bmj.com
Background and purpose Thrombus formation during endovascular embolization of
intracranial aneurysms occurs in 2.9%–6% of patients. Use of IIb/IIIA inhibitors such as …
intracranial aneurysms occurs in 2.9%–6% of patients. Use of IIb/IIIA inhibitors such as …
Related searches
- thromboembolic events intraarterial administration
- intracranial aneurysm coil embolization
- thromboembolic events treatment modalities
- thromboembolic events rescue therapy
- thromboembolic events center experience
- thrombus formation intracranial aneurysms
- thromboembolic complications intracranial aneurysms
- thrombus formation coil embolization
- abciximab for treatment intracranial aneurysms
- abciximab for treatment thromboembolic complications
- abciximab and tirofiban coil embolization
- intracranial aneurysm comparison of abciximab
- intracranial aneurysm abciximab and tirofiban
- intracranial aneurysm treatment of thromboembolism
- endovascular coiling intracranial aneurysms
- comparison of abciximab coil embolization